SCECX
Price
$14.50
Change
-$0.01 (-0.07%)
Updated
Jul 31 closing price
Net Assets
194.63M
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

SCECX vs VSCIX

SCECX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
SCECX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SCECX is a Buy and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. SCECX (195M). VSCIX pays higher dividends than SCECX: VSCIX (1.23) vs SCECX (0.67). SCECX was incepted earlier than VSCIX: SCECX (20 years) vs VSCIX (29 years). SCECX (0.64) is less costly to investors than VSCIX (0.03). SCECX is a more actively managed with annual turnover of: 36.00 vs. VSCIX (17.00). SCECX has a lower initial minimum investment than VSCIX: SCECX (100000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.58 vs. SCECX (14.78). VSCIX return over 5 years is better than : 35.13 vs. SCECX (-15.96).
SCECXVSCIXSCECX / VSCIX
Total Expense Ratio0.640.032,133%
Annual Report Gross Expense Ratio0.640.032,133%
Fund Existence20 years29 years-
Gain YTD15.81514.591108%
Front LoadN/AN/A-
Min. Initial Investment10000050000002%
Min. Initial Investment IRAN/AN/A-
Net Assets195M189B0%
Annual Yield % from dividends0.671.2355%
Returns for 1 year14.7822.5865%
Returns for 3 years19.3143.4444%
Returns for 5 years-15.9635.13-45%
Returns for 10 years12.22156.078%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C